Winton Matthew bought CRVO
February 11, 2026 · Form 4 insider transaction
Winton Matthew bought 30,000 shares of CervoMed Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderWinton Matthew
RoleOfficer
CompanyCervoMed Inc. (CRVO)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026.